About Yangzhou First People's Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Yangzhou First People's Hospital
During the past decade, Yangzhou First People's Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on
average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Yangzhou First People's Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Anji Pharma" with 1 trials
sponsored, "Capital Medical University" with 1 trials sponsored, "Eisai China Inc." with 1 trials sponsored and "Jiangsu Cancer Institute & Hospital"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Yangzhou First People's Hospital"
#1 collaborator was "Covance" with 1 trials as a collaborator, "Northern Jiangsu Province People's Hospital" with 1 trials as a collaborator and "Xinjiang Uygur Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Yangzhou First People's Hospital
According to Clinical.Site data, the most researched conditions in "Yangzhou First People's Hospital" are
"Crohn's Disease" (3 trials), "Abnormal Mucus Secretions" (1 trials), "Advanced Colorectal Cancer" (1 trials), "Alzheimer Disease" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "Yangzhou First People's Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Yangzhou First People's Hospital
Most popular intervention types in "Yangzhou First People's Hospital" are "Drug" (12 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Guselkumab" (2 trials), "Ustekinumab" (2 trials), "Ambroxol hydrochloride 30 mg" (1 trials) and "Amoxicillin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Yangzhou First People's Hospital
The vast majority of trials in "Yangzhou First People's Hospital" are
14 trials for "All" genders.
Clinical Trials Status at Yangzhou First People's Hospital
Currently, there are NaN active trials in "Yangzhou First People's Hospital".
undefined are not yet recruiting,
7 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Yangzhou First People's Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Yangzhou First People's Hospital, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".